Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2014; 20(46): 17483-17490
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17483
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17483
Figure 1 Overall survival curve of 86 patients who underwent transarterial chemoembolization-microwave ablation.
TACE: Transarterial chemoembolization; MWA: Microwave ablation.
- Citation: Ni JY, Sun HL, Chen YT, Luo JH, Chen D, Jiang XY, Xu LF. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma. World J Gastroenterol 2014; 20(46): 17483-17490
- URL: https://www.wjgnet.com/1007-9327/full/v20/i46/17483.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i46.17483